County Of San Joaquin Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd Ste A, French Camp, CA 95231 Phone: 209-468-6937 Fax: 209-468-6114 |
San Joaquin Faculty Medical Group Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 Hospital Rd, French Camp, CA 95231 Phone: 209-473-6555 Fax: 209-473-6544 |
San Joaquin County Clinics Fmc Clinic/Center - Multi-Specialty Medicare: Medicare Enrolled Practice Location: 500 West Hospital Rd Suite B, French Camp, CA 95231 Phone: 209-953-6400 Fax: 209-468-6212 |
San Joaquin County Clinics Hbf Clinic/Center - Multi-Specialty Medicare: Medicare Enrolled Practice Location: 500 W Hospital Rd Suite A, French Camp, CA 95231 Phone: 209-953-6400 Fax: 209-468-7177 |
San Joaquin County Clinics Pmc Clinic/Center - Multi-Specialty Medicare: Medicare Enrolled Practice Location: 500 W Hospital Rd Suite C, French Camp, CA 95231 Phone: 209-953-6400 Fax: 209-468-7162 |
San Joaquin County Clinics Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd Ste A, French Camp, CA 95231 Phone: 209-468-6820 |
News Archive
The United States health care system is generally centered around hospitals and specialty care. The value of primary care, however, has remained unclear and debated, in part due to limited research.
In a new study, researchers at Uppsala University now demonstrate that one night of sleep loss has a tissue-specific impact on the regulation of gene expression and metabolism in humans.
The future begins now - that is the mantra on medical courses at MedUni Vienna and also at the Society for Medical Education conference starting in Vienna this coming Wednesday - the largest event on this topic within the German-speaking area.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that it has submitted an application under the European Mutual Recognition Procedure seeking to expand the marketing authorization for Sativex into France for the treatment of spasticity due to Multiple Sclerosis.
› Verified 9 days ago